Alvotech (ALVO)

NASDAQ: ALVO · Real-Time Price · USD

10.58

+0.02 (0.19%)

May 14, 2025, 2:21 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biosimilar Medicines	91.43M	Log In
Biosimilar Medicines Growth	10.12%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Europe	63.51M	Log In
Europe Growth	61.06%	Log In
North America	18.31M	Log In
North America Growth	-40.53%	Log In
Asia and Other	9.62M	Log In
Asia	-	Log In
Other	-	Log In